Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Alvotech ALVO

Healthcare Drug Manufacturers - Specialty & Generic
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:ALVO)

Fundamentals Snapshot (NDAQ:ALVO)

Current News (NDAQ:ALVO)

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVOW

PR Newswire 2 days ago

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses to Contact the Firm

Accesswire 4 days ago

Alvotech and Advanz Pharma extend strategic partnership to commercialize five proposed biosimilars in Europe

GlobeNewswire 5 days ago

Alvotech Reports Financial Results for First three Months of 2023 and Provides Business Update

GlobeNewswire 10 days ago

Alvotech to Participate in Morgan Stanley Annual Sustainable Finance Summit

GlobeNewswire 12 days ago

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm

Accesswire 12 days ago

Alvotech Issues Annual Equality Report Covering 2022

GlobeNewswire May 15, 2023

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Alvotech and Encourages Investors with Losses to Contact the Firm

Accesswire May 12, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO

PR Newswire May 10, 2023
View More News ››

Opinion & Analysis (NDAQ:ALVO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALVO)

Be the first to post on this bullboard.

Dona Blanca Ltd.

Dona Blanca Ltd.

Dona Blanca intends to trade on the TSX Venture under the ticker TSXV:DBL. Dona Blanca grows high-quality cannabis in ...
View More »